BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7820141)

  • 1. Size and status of metastases after inductive chemotherapy of germ-cell tumors. Indication for salvage operation.
    Jaeger N; Weissbach L; Bussar-Maatz R
    World J Urol; 1994; 12(4):196-9. PubMed ID: 7820141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors.
    Aprikian AG; Herr HW; Bajorin DF; Bosl GJ
    Cancer; 1994 Aug; 74(4):1329-34. PubMed ID: 8055456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses.
    Hendry WF; Norman AR; Dearnaley DP; Fisher C; Nicholls J; Huddart RA; Horwich A
    Cancer; 2002 Mar; 94(6):1668-76. PubMed ID: 11920527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of resections for residual masses after chemotherapy in metastatic testicular tumors.
    Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Saito S; Ohyama C; Sato M; Kawamura S; Numahata K; Ito A; Tokuyama S
    Int J Urol; 1999 Jun; 6(6):305-13. PubMed ID: 10404307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors.
    Hartmann JT; Schmoll HJ; Kuczyk MA; Candelaria M; Bokemeyer C
    Ann Oncol; 1997 Jun; 8(6):531-8. PubMed ID: 9261521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group.
    Albers P; Weissbach L; Krege S; Kliesch S; Hartmann M; Heidenreich A; Walz P; Kuczyk M; Fimmers R;
    J Urol; 2004 May; 171(5):1835-8. PubMed ID: 15076288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Hartmann JT; Candelaria M; Kuczyk MA; Schmoll HJ; Bokemeyer C
    Eur J Cancer; 1997 May; 33(6):843-7. PubMed ID: 9291803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late recurrence with malignant degeneration of testicular teratoma. Case report.
    Bulbul MA; Farhat W; Shabb NS; Salem Z
    J Med Liban; 1998; 46(2):103-5. PubMed ID: 10095838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
    Winter C; Pfister D; Busch J; Bingöl C; Ranft U; Schrader M; Dieckmann KP; Heidenreich A; Albers P
    Eur Urol; 2012 Feb; 61(2):403-9. PubMed ID: 22078334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation policy for residual masses after chemotherapy for gonadal and extra-gonadal germ cell tumors].
    Takizawa A; Miura T; Fujinami K; Osada Y
    Hinyokika Kiyo; 2005 Apr; 51(4):247-51. PubMed ID: 15912783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual masses after chemotherapy for metastatic testicular cancer: the clinical implications of the association between retroperitoneal and pulmonary histology. Re-analysis of Histology in Testicular Cancer (ReHiT) Study Group.
    Steyerberg EW; Donohue JP; Gerl A; Toner GC; Schraffordt Koops H; Fosså SD; Keizer HJ
    J Urol; 1997 Aug; 158(2):474-8. PubMed ID: 9224327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group.
    Steyerberg EW; Keizer HJ; Messemer JE; Toner GC; Schraffordt Koops H; Fosså SD; Gerl A; Sleijfer DT; Donohue JP; Habbema JD
    Cancer; 1997 Jan; 79(2):345-55. PubMed ID: 9010108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.
    Sonneveld DJ; Sleijfer DT; Koops HS; Keemers-Gels ME; Molenaar WM; Hoekstra HJ
    Cancer; 1998 Apr; 82(7):1343-51. PubMed ID: 9529027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
    Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
    Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.
    Gels ME; Hoekstra HJ; Sleijfer DT; Nijboer AP; Molenaar WM; Ebels T; Schraffordt Koops H
    Chest; 1997 Oct; 112(4):967-73. PubMed ID: 9377960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
    Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
    Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and clinical outcome of patients with teratoma in the retroperitoneum following primary retroperitoneal lymph node dissection for clinical stages I and IIA nonseminomatous germ cell tumors.
    Sheinfeld J; Motzer RJ; Rabbani F; McKiernan J; Bajorin D; Bosl GJ
    J Urol; 2003 Oct; 170(4 Pt 1):1159-62. PubMed ID: 14501715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.